CAS 1830330-31-8

Fórmula: C22H18FN7O

InChI: InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1/i3D,4D,5D,7D,8D

Clave InChI: IFSDAJWBUCMOAH-LPJONKDZSA-N

SMILES: [2H]C1=C(C(=C(C(=C1[2H])[2H])N2C(=O)C3=C(C=CC=C3F)N=C2[C@H](CC)NC4=NC=NC5=C4NC=N5)[2H])[2H]

Idelalisib-d5

CAS: 1830330-31-8

Idelalisib-d5

Fórmula: C₂₂H₁₃D₅FN₇O

Pureza: 98.35%

Peso molecular: 420.45

Ref: 54-DE2279

Idelalisib-d5

CAS: 1830330-31-8

Pureza: 98.35%

Ref: IN-DA01QIPP

Idelalisib-D5

CAS: 1830330-31-8

Idelalisib-D5, deuterated Idelalisib (phenyl H→D). Idelalisib is an oral selective p110δ inhibitor.

Fórmula: C₂₂H₁₈FN₇O

Pureza: 98%

Forma y color: Solid

Peso molecular: 420.45

Ref: TM-T11610

Idelalisib D5

CAS: 1830330-31-8

Ref: BE-RMCI020014